Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,700.00

Mettler-Toledo International (NYSE:MTD) had its price objective hoisted by Barclays from $1,575.00 to $1,700.00 in a report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock.

Several other research firms have also commented on MTD. Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Rothschild & Co Redburn initiated coverage on Mettler-Toledo International in a research report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price objective on the stock. Jefferies Financial Group lifted their target price on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a “buy” rating in a research note on Friday, July 31st. UBS Group assumed coverage on shares of Mettler-Toledo International in a report on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 target price for the company. Finally, Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, September 8th. Five equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $1,459.54.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,551.26 on Wednesday. The company has a market cap of $31.09 billion, a PE ratio of 34.91, a P/E/G ratio of 3.06 and a beta of 1.19. The firm’s 50 day moving average price is $1,424.82 and its 200-day moving average price is $1,301.70. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. Mettler-Toledo International has a 52-week low of $1,023.05 and a 52-week high of $1,585.72.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. Mettler-Toledo International’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $10.09 earnings per share. Sell-side analysts forecast that Mettler-Toledo International will post 47.35 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the transaction, the chief executive officer directly owned 4,480 shares of the company’s stock, valued at approximately $6,384,000. This represents a 17.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 2,240 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the completion of the transaction, the chief financial officer owned 5,579 shares in the company, valued at approximately $7,989,128. This trade represents a 28.65% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 4,254 shares of company stock worth $6,092,712. 0.71% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Wedmont Private Capital purchased a new stake in Mettler-Toledo International in the 3rd quarter worth $457,000. GAMMA Investing LLC lifted its holdings in Mettler-Toledo International by 6.9% during the third quarter. GAMMA Investing LLC now owns 647 shares of the medical instruments supplier’s stock valued at $978,000 after purchasing an additional 42 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Mettler-Toledo International by 32.7% in the third quarter. Farther Finance Advisors LLC now owns 150 shares of the medical instruments supplier’s stock valued at $227,000 after purchasing an additional 37 shares during the period. Plan A Wealth LLC grew its position in shares of Mettler-Toledo International by 1.9% in the third quarter. Plan A Wealth LLC now owns 373 shares of the medical instruments supplier’s stock valued at $564,000 after purchasing an additional 7 shares during the period. Finally, Congress Asset Management Co. purchased a new stake in shares of Mettler-Toledo International during the third quarter worth about $213,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer of precision instruments and related services used in laboratory, industrial, food processing, pharmaceutical and retail applications. The company’s solutions help customers measure, analyze, inspect and control materials and products throughout research, manufacturing and distribution processes.

Its product portfolio includes laboratory balances and scales, analytical instruments, automated chemistry systems, titrators, density and refractometry equipment, process analytics, industrial weighing systems, product inspection technologies and retail weighing and labeling solutions.